Invertec

Invetx is a pioneer in the field of veterinary biotherapeutics, focused on developing high-quality, species-specific monoclonal antibodies for companion animals. The company leverages a proprietary platform that integrates advanced antibody discovery and optimization technologies to create therapies that are specifically tailored for dogs and cats. Their pipeline addresses significant unmet needs in animal health, including chronic pain management and inflammatory diseases such as atopic dermatitis. By applying human-grade biotechnology standards to veterinary medicine, Invetx aims to extend the reach of precision medicine to the animal health sector.